Smellprints in lung Cancer; the role of ENose in diagnosis and Treatment (SCENT): part 2. Identification of patients with lung cancer and breast cancer.
Completed
- Conditions
- lung cancer or bronchial carcinoma/ breast cancer or mamma carcinoma1002910710006291
- Registration Number
- NL-OMON32897
- Lead Sponsor
- Medisch Centrum Leeuwarden
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- Not specified
- Target Recruitment
- 300
Inclusion Criteria
1. all women (18-80 yr) suspected of having breast cancer, referred to the OPD specialised in the diagnostic work-up of breast abnormalities in our hospital (*mamma poli*) will be asked to participate (intention-to-diagnose).
2. all patients (18-80 yr) suspected of having lung cancer, referred to the pulmonary OPD in our hospital will be asked to participate (intention-to-diagnose).
Exclusion Criteria
Patients of whom it is not possible to make the diagnose lung cancer or breast cancer.
eating (including chewing gum), drinking,brushing teeth, smoking < 3 hours before measurements.
Study & Design
- Study Type
- Observational non invasive
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method <p>Sensitivity, specificity, positive and negative predictive value of the eNose<br /><br>combined with the statistical algorithm developed from the training-set in the<br /><br>SCENT study part 1. </p><br>
- Secondary Outcome Measures
Name Time Method <p>not applicable</p><br>